ATS Corporation
ATSAF
Updated: 24/09/2026, 09:43:54
No historical data available
ATS Corporation furnishes advanced automation solutions to clients across the globe. The company oversees the complete lifecycle of automated manufacturing and assembly systems, spanning from initial conceptualization and engineering to construction, deployment, and ongoing maintenance, while also providing its own automation products and sophisticated testing capabilities. ATS offers extensive enterprise-level support, which includes project oversight, supplier coordination, facility planning, business case development, and critical post-project services such as spare parts, continuous support, system validation, and training. Its service portfolio further encompasses pre-automation activities like discovery, concept refinement, simulation, and total cost analysis, as well as post-automation assistance covering user training, process optimization, routine maintenance, emergency support, and equipment refurbishment or relocation. Additionally, ATS undertakes contract manufacturing and a broad array of engineering and technical services, including design, prototyping, software development, equipment integration, and comprehensive documentation. The corporation serves diverse sectors such as life sciences, transportation, consumer products, food and beverage, and energy. Established in 1978 and headquartered in Cambridge, Canada, the company rebranded to ATS Corporation in November 2022, having previously operated as ATS Automation Tooling Systems Inc.
No summaries found.
- Share price
- $44.25
- Market cap
- $4.06B
- Exchange
- OTC
- Currency
- USD
- CEO
- Andrew P. Hider
- Employees
- 6,000
- IPO date
- 29/12/2009
- Beta
- 1.627027
- Last dividend
- $0.00
- Day range
- $44.25 – $44.25
- 52-week range
- $25.66 – $45.80
- 1-day performance
- 0.00%
- 1-year performance
- 72.45%
- Current drawdown (1Y)
- -3.38%
- CIK
- N/A
- CUSIP
- N/A
- ISIN
- N/A
- Created
- 07/12/2025, 02:12:19
- Last update
- 24/09/2026, 09:43:54
Track ATS Corporation with an AI analyst
See which prediction-market events move ATSAF, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.
Free forever to follow AlphaBrain’s AI strategies. No card required.
ATS to Participate in the Stifel Summer Solstice Conference
Business Wire • STOCK • 08/06/2026, 19:00:00
TD Securities Bullish on ATS Corp. (ATSAF) After Mixed Q4 Results
Market Data • Market Data • 29/05/2026, 19:13:18
ATS Q4 Earnings Call Highlights
MarketBeat • STOCK • 28/05/2026, 14:10:41
ATS (ATS) Q4 Earnings Lag Estimates
Zacks Investment Research • STOCK • 28/05/2026, 10:16:09
MiNK Therapeutics Reports New Data on agenT-797, an allo-iNKT Cell Therapy at ATS 2026; Simultaneously Published in Clinical Immunology Communications
GlobeNewsWire • STOCK • 20/05/2026, 13:07:00
United Therapeutics Corporation Announces TETON-1 Study of Tyvaso Published in The New England Journal of Medicine and Presented at ATS 2026
Business Wire • STOCK • 18/05/2026, 18:15:00
Press Release: ATS: phase 2 data demonstrate the superiority of efdoralprin alfa over a standard-of-care augmentation therapy in achieving higher fAAT levels in AATD
GlobeNewsWire • STOCK • 18/05/2026, 17:30:00
Upstream Bio Presents New Data from Phase 2 VIBRANT Trial of Verekitug Demonstrating Improvement in Asthma Symptom Control in Participants with CRSwNP and Comorbid Asthma at the ATS 2026 International Conference
GlobeNewsWire • STOCK • 18/05/2026, 13:30:00
United Therapeutics Corporation Announces ADVANCE OUTCOMES Study of Ralinepag Presented at ATS 2026
Business Wire • STOCK • 17/05/2026, 16:15:00
Upstream Bio to Present New Data from Phase 2 VIBRANT Trial of Verekitug at the ATS 2026 International Conference
GlobeNewsWire • STOCK • 17/04/2026, 09:00:00
MiNK Therapeutics Announces Abstract Acceptance for Presentation at the American Thoracic Society (ATS) 2026 International Conference
GlobeNewsWire • STOCK • 01/04/2026, 09:30:00
ATS (ATS) Tops Q3 Earnings and Revenue Estimates
Zacks Investment Research • STOCK • 04/02/2026, 09:21:09